NIHR: Improving the health and wealth of the nation through research




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: NIHR: Improving the health and wealth of the nation through research
Released on: July 08, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Professor Nicholas Lemoine (Medical Director at the National Institute for Health Research (NIHR)) describes the aims behind NIHR’s health research system, an NHS initiative supporting outstanding individuals conducting cutting-edge research focused on the needs of patients and the public.
  • Summary
  • Transcript
  • Participants
  • Company
Professor Nicholas Lemoine (Medical Director at the National Institute for Health Research (NIHR)) describes the aims behind NIHR’s health research system, an NHS initiative supporting outstanding individuals conducting cutting-edge research focused on the needs of patients and the public.
Professor Nicholas Lemoine (Medical Director at the National Institute for Health Research (NIHR)) describes the aims behind NIHR’s health research system, an NHS initiative supporting outstanding individuals conducting cutting-edge research focused on the needs of patients and the public.
Professor Nick Lemoine is the Medical Director of the NIHR Clinical Research Network, having joined the Executive Team in May 2014. His primary role is to direct the Theme Leads and Specialty National Leads in the development of strategic and implementation plans to support the delivery of high quality research studies by a well trained workforce. His senior team will also be working on the implications of emerging technologies and innovations for the Network, exploiting the wealth of intelligence and experience in the five Universities that constitute the Alliance Partnership (Leeds, Liverpool, Newcastle, Imperial College and Kings College London). Nick trained in physiology and medicine at St Bartholomew’s Hospital Medical College, graduating with the University of London Gold Medal. He subsequently undertook both a PhD at the University of Wales and then an MD degree at The University of London. His clinical training in pathology and molecular oncology was completed at University Hospital of Wales in Cardiff and the Royal Postgraduate Medical School at Hammersmith Hospital. In 1996 he was made a Professor at Imperial College where he directed the CR-UK Molecular Oncology Unit focusing on biological therapies including vaccines for cancer, and then in 2004 moved to become Director of the Barts Cancer Institute in London which has recently been ranked as one of the world’s top ten University departments of cancer research. He is also presently Director of Research & Development for Cancer & Surgery at Barts Health NHS Trust, the largest NHS Trust in the country. Nick was elected as a Fellow of the Royal College of Pathologists in 1996 and as a Fellow of the Academy of Medical Sciences in 2006. Among other commitments, he is the new Chair of Trustees of the Medical Research Foundation (the MRC’s £50M charity) and the Chair of the Research Advisory Boards of Diabetes UK, Prostate Cancer UK, Pancreatic Cancer Research Fund as well as Chair of the NIHR i4i Challenge Award Panel.
2016 marks a decade since the National Institute for Health Research (NIHR) was established. Throughout the last ten years it has contributed significantly to the health and wealth of the nation and is now the most comprehensive research system in the world. The NIHR supports research from bench to bedside for the benefit of patients and the economy. It works with patients and the public to shape the research agenda, finding new ways of preventing, identifying and treating ill health, evaluating the effectiveness and impact of new healthcare treatments, and ensures that the best possible evidence is available to inform decisions about health and social care. The NIHR attracts investment into the UK by supporting partnerships with life science companies, including small and medium enterprises, and charities, and builds capacity and leadership in the research workforce.